Health and Beauty: 14/02/08

Canadian Health Network's Healthlink for February 14, 2008

Problems viewing this newsletter? Visit our online version at
www.canadian-health-network.ca/special/newsletter/feb14_08_e.html

February 14, 2008

Welcome to Healthlink, a twice-monthly e-newsletter of the Canadian Health Network, your preferred health information source. We deliver you the latest information on healthy lifestyles and health promotion information to help you stay healthy and prevent disease and injury.

Turn off the car!
	Idling your engine is bad for you, the air... and your car!

Raising resilient kids
	Give your kids the skills to bounce back...

	WinterActive
	Black History Month
	Heart Month
	Sexual and Reproductive Health Day

Roses are red, violets are blue, are artificial sweeteners good for you?

Find out!

These winter recipes will warm your heart!

King County Alcohol and Drug Abuse Trends Update

You are subscribed to Alcohol and Drug Abuse Trends for Public Health - Seattle & King County.

The latest report of the King County Alcohol and Drug Abuse Trends Update with data through the first half of 2007 is now available online at http://www.metrokc.gov/health/subabuse

# # #

You can update or cancel your subscription at any time by clicking here. All you will need are your e-mail address and your password (if you have selected one).

This service is provided free of charge by: Public Health - Seattle & King County.

P.S. If you have any questions or problems with the subscription service e-mail support@govdelivery.com for assistance. All other inquiries can be directed to publichealth@kingcounty.gov.

GovDelivery, Inc. sending on behalf of Public Health - Seattle & King County. 380 Jackson Street Suite 550, St. Paul, MN 55101. 1-800-439-1420

King County Board of Health meeting on February 21, 2008

Public Health Press Release

You are subscribed to Press Releases for Public Health - Seattle & King County.

The agenda for the February 21, 2008 King County Board of Health meeting is now available at http://www.metrokc.gov/health/news/08021401.htm

Key topics on the agenda:

Work programs for the injury prevention, obesity prevention and provision committees of the King County Board of Health.
A briefing on a "friend of the court" brief supporting State Board of Pharmacy rules regarding pharmacy's/pharmacist's responsibilities to fill legal prescriptions.
Proposed 2008 Enhanced HIV Prevention Projects
State Legislative Update
An update on continuity and emergency preparedness planning

# # #

You can update or cancel your subscription at any time by clicking here. All you will need are your e-mail address and your password (if you have selected one).

This service is provided free of charge by: Public Health - Seattle & King County.

P.S. If you have any questions or problems with the subscription service e-mail support@govdelivery.com for assistance. All other inquiries can be directed to publichealth@kingcounty.gov.

GovDelivery, Inc. sending on behalf of Public Health - Seattle & King County. 380 Jackson Street Suite 550, St. Paul, MN 55101. 1-800-439-1420

King County HIV/AIDS Statistics Update

HIV/AIDS Epidemiology Statistics

You are subscribed to HIV/AIDS Statistics for Public Health - Seattle & King County.

The Monthly HIV/AIDS Epidemiology Report for King County through 1/31/08 is now updated online at http://www.metrokc.gov/health/apu/epi/epistats.htm

# # #

You can update or cancel your subscription at any time by clicking here. All you will need are your e-mail address and your password (if you have selected one).

This service is provided free of charge by: Public Health - Seattle & King County.

P.S. If you have any questions or problems with the subscription service e-mail support@govdelivery.com for assistance. All other inquiries can be directed to publichealth@kingcounty.gov.

GovDelivery, Inc. sending on behalf of Public Health - Seattle & King County. 380 Jackson Street Suite 550, St. Paul, MN 55101. 1-800-439-1420

HIV/AIDS Update - Zidovudine Tablets, 300 mg.

You are receiving this message as a subscriber to the FDA HIV/AIDS electronic list serve. The purpose of the list serve is to relay important information about HIV/AIDS-related products and issues, including product approvals, significant labeling changes, safety warnings, notices of upcoming public meetings and alerts to proposed regulatory guidances for comment.

Please do not reply to this message.

On February 14, 2008, FDA granted approval for a generic formulation of Zidovudine Tablets, 300 mg., manufactured by Matrix Laboratories, Inc. of Hyderabad, India. The application was reviewed under the expedited review provisions of the President’s Emergency Plan for AIDS Relief (PEPFAR). However, because patent protections for the reference product, Retrovir Tablets,300 mg, made by GlaxoSmithKline have expired, this generic product can be marketed in the United States, as well as being available for purchase under the PEPFAR program.

A list of all FDA approved generic antiretroviral drugs for the treatment of HIV is available on the web at http://www.fda.gov/oashi/aids/viralsgeneric.html

Zidovudine is a Nucleoside Reverse Transcriptase Inhibitors (NRTI) indicated for the treatment of HIV in combination with other antiviral medications.

As with all FDA-approved generics, this product must meet all of FDA's manufacturing quality, and clinical safety and effectiveness standards.

Richard Klein
Office of Special Health Issues
Food and Drug Administration

Kimberly Struble
Division of Antiviral Drug Products
Food and Drug Administration

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Summit Import Corporation Issues Allergy Alert on Undeclared Sulfites in Oriental Mascot Brand Sweetened Sliced Coconut (Feb. 1)

Summit Import Corporation Issues Allergy Alert on Undeclared Sulfites in Oriental Mascot Brand Sweetened Sliced Coconut (Feb. 1)
Thu, 14 Feb 2008 11:45:00 -0600

Summit Import Corp. is recalling "Oriental Mascot Brand Sweetened Sliced Coconut" because it contains undeclared sulfites. Consumers who have severe sensitivity to sulfites may run the risk of serious or life-threatening allergic reactions if they consume this product. The product comes in an uncoded 4 oz plastic container. The recalled "Oriental Mascot Brand Sweetened Sliced Coconut" was distributed in New York State.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Enforcement Report for February 13, 2008

Enforcement Report for February 13, 2008
Thu, 14 Feb 2008 05:46:00 -0600

Weekly report by the Food and Drug Administration, Department of Health and Human Services. It contains information on actions taken in connection with agency Regulatory activities.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

U.S. Food & Drug Administration (FDA) Workshops and Conferences Update

You are subscribed to Workshops and Conferences for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.

The Eleventh US-Japan Cellular and Gene Therapy Conference on Tissue Engineering - February 28, 2008

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Archive